The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy people

Salaffi, Fausto; Carotti, Marina; Gasparini, Stefania; Intorcia, Michele; Grassi, Walter

doi:10.1186/1477-7525-7-25

Cited by 307 publications

(232 citation statements)

References 42 publications

Supporting

Mentioning

193

Contrasting

Unclassified

Order By: Relevance

“…Moreover, psoriatic skin manifestations in PsA have the impact on emotional and social functioning [7,8]. SF-36 survey has been widely used by numerous studies to assess QOL in chronic rheumatic diseases [4,5,8,10,[26][27][28][29][30]. We used Croatian version of SF-36 QOL questionnaire and, even though we had rather limited number of patients within groups, obtained strong correlations between different clinical variables and several SF-36 health concepts for those diseases.…”

Section: Discussionmentioning

confidence: 99%

“…AS predominantly affects axial skeleton with the involvement of sacroiliac joints, and often also entheses and extra-articular structures. It leads to irreversible structural changes causing decreased spinal mobility [4,5]. PsA may involve both the peripheral joints and spine, with variable incidence.…”

Section: Introductionmentioning

confidence: 99%

“…PsA may involve both the peripheral joints and spine, with variable incidence. In addition to the joint involvement patient with PsA have a skin disease [4,6]. The combination of joint and skin manifestations of PsA has a specific impact on patient functioning, well being and quality of life (QOL) [7,8] The aim of this study was to validate the clinical variables that most accurately correlate with QOL in patients with AS and PsA.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Which clinical variables have the most significant correlation with quality of life evaluated by SF-36 survey in Croatian cohort of patient with ankylosing spondylitis and psoriatic arthritis?

Jajić¹,

Rajnpreht²,

Kovačić

et al. 2011

Rheumatol Int

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Which clinical variables have the most significant correlation with quality of life evaluated by SF-36 survey in Croatian cohort of patient with ankylosing spondylitis and psoriatic arthritis?

Jajić¹,

Rajnpreht²,

Kovačić

et al. 2011

Rheumatol Int

View full text Add to dashboard Cite

show abstract

“…An elevated risk of cardiovascular disease is also known to occur in psoriasis,50 and is responsible for 20–56% of deaths in patients with PsA 51. Alongside high disease activity, the presence of co‐morbidity has been found to impact health‐related QoL (HRQoL) in patients with PsA 49. Moreover, patients with PsA can have a significantly lower HRQoL than the general population 39, 49…”

Section: Mitigating the Impact Of Psa On The Patientmentioning

confidence: 99%

“…Alongside high disease activity, the presence of co‐morbidity has been found to impact health‐related QoL (HRQoL) in patients with PsA 49. Moreover, patients with PsA can have a significantly lower HRQoL than the general population 39, 49…”

Section: Mitigating the Impact Of Psa On The Patientmentioning

confidence: 99%

Promoting patient‐centred care in psoriatic arthritis: a multidisciplinary European perspective on improving the patient experience

Betteridge

Boehncke

Bundy

et al. 2015

Acad Dermatol Venereol

View full text Add to dashboard Cite

Patients with psoriatic arthritis (PsA) may not be optimally treated. The impact of the disease extends beyond skin and joint symptoms, impairing quality of life. This indicates that the adoption of a patient‐focused approach to PsA management is necessary. An expert multidisciplinary working group was convened, with the objective of developing an informed perspective on current best practice and needs for the future management of PsA. Topics of discussion included the barriers to current best practice and calls to action for the improvement of three areas in PsA management: early and accurate diagnosis of PsA, management of disease progression and management of the impact of the condition on the patient. The working group agreed that, to make best use of the available of diagnostic tools, clinical care recommendations and effective treatments, there is a clear need for healthcare professionals from different disciplines to collaborate in the management of PsA. By facilitating appropriate and rapid referral, providing high quality information about PsA and its treatment to patients, and actively involving patients when choosing management plans and setting treatment goals, management of PsA can be improved. The perspective of the working group is presented here, with recommendations for the adoption of a multidisciplinary, patient‐focused approach to the management of PsA.

show abstract

Longitudinal study of the bidirectional association between pain and depressive symptoms in patients with psoriatic arthritis

Husted¹,

Tom²,

Farewell³

et al. 2012

Arthritis Care & Research

View full text Add to dashboard Cite

Objective. To test the bidirectional hypothesis that depressive symptoms influence changes in pain over time, and pain influences changes in depressive symptoms. Methods. A total of 394 patients attending the University of Toronto Psoriatic Arthritis clinic were followed over a mean period of 7.5 years with annual assessments, including number of swollen joints (SJC), Health Assessment Questionnaire (HAQ), and the Medical Outcomes Survey Short Form 36 (SF-36). Linear mixed-effects models were used to examine the cross-and lagged associations between the changes in HAQ pain and in the SF-36 mental component summary (MCS) score, adjusting for SJC and other covariates. Results. The strongest predictors of changes in pain, SJC, and depressive symptoms between visits were scores of the corresponding variables at the previous visit, with standardized regression coefficients exceeding 0.75 in absolute value. There was, however, evidence of a small, but consequential, bidirectional relationship (i.e., standardized regression coefficients <0.3) between depressive symptoms and pain. Both previous MCS scores and change in MCS scores were associated with change in pain between visits; conversely, previous pain scores and change in pain scores were associated with change in depressive symptoms between visits. Conclusion. Even though cross-variable associations between pain and depressive symptoms exist, changes in pain and depressive symptoms appear to be strongly driven by their measurements at the previous visit. To optimize patient outcomes, a clinical approach that assesses and treats clinically significant depressive symptoms, as well as pain, is required.

show abstract

The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy people

Cited by 307 publications

References 42 publications

Which clinical variables have the most significant correlation with quality of life evaluated by SF-36 survey in Croatian cohort of patient with ankylosing spondylitis and psoriatic arthritis?

Which clinical variables have the most significant correlation with quality of life evaluated by SF-36 survey in Croatian cohort of patient with ankylosing spondylitis and psoriatic arthritis?

Promoting patient‐centred care in psoriatic arthritis: a multidisciplinary European perspective on improving the patient experience

Longitudinal study of the bidirectional association between pain and depressive symptoms in patients with psoriatic arthritis

Contact Info

Product

Resources

About